ADMINISTER iovera° RIGHT WHERE YOU PRACTICE.

TARGET NERVES RIGHT WHERE THEY ARE.

You have options for administration using anatomical or ultrasound guidance.

Establishing treatment lines (Landmark technique)

  • Draw the AFCN treatment line
  • Draw the ISN treatment line
  • Follow nerve treatment techniques
    • For nerves identified by anatomic landmarks, treat along the entire line
    • Obtain patient feedback during treatment cycles
landmark technique img

Anatomical landmark treatment technique video

Watch Vernon Williams, MD, Director for Sports Neurology
and Pain Medicine at Cedars-Sinai Kerlan-Jobe Institute review pre-treatment assessment, nerve identification, treatment protocol, and post-treatment assessment.

 

AFCN under ultrasound

  • Ultrasound identification is an option for precise targeting of nerves, but not required when using the Smart Tip 2309
  • Ultrasound use is required for nerve targeting with the Smart Tip 2190
afcn under ultrasound img
ice left
 

GEN 2 SYSTEM GUIDE VIDEO

The Gen 2 System Guide video provides you with instructions on setup, priming, attaching Smart Tips, and replacing Cartridges. Please see the full User Guide for detailed instructions.

SEE USER GUIDE

AFCN=anterior femoral cutaneous nerve; ISN=infrapatellar branch of saphenous nerve.

ice right

See iovera° in action

schedule a demo

Get started with iovera°

GET YOUR PRACTICE TOOLKIT

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue.

When stimulation compatible components are used, the iovera° system can also facilitate target nerve location by conducting electrical nerve stimulation from a compatible 3rd party nerve stimulator.

Important Safety Information

Contraindications

The iovera° system is contraindicated for use in patients with the following:

  • Cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud’s disease, and open and/or infected wounds at or near the treatment site

Potential Complications

As with any surgical treatment that uses needle-based therapy and local anesthesia, there is a potential for site-specific reactions, including, but not limited to:

  • Ecchymosis, edema, erythema, local pain and/or tenderness, and localized dysesthesia

Proper use of the device as described in the User Guide can help reduce or prevent the following complications:

  • At the treatment site(s): injury to the skin related to application of cold or heat, hyper- or hypopigmentation, and skin dimpling
  • Outside the treatment site(s): loss of motor function
More +

Indication

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain.

Important Safety Information